Literature DB >> 4698338

Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome.

W W McCrory, M Shibuya, W H Lu, J E Lewy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4698338     DOI: 10.1016/s0022-3476(73)80586-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  8 in total

Review 1.  Corticosteroid therapy for nephrotic syndrome in children.

Authors:  Deirdre Hahn; Elisabeth M Hodson; Narelle S Willis; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2015-03-18

2.  Minimal change nephrotic syndrome and cyclophosphamide.

Authors:  R S Trompeter
Journal:  Arch Dis Child       Date:  1986-08       Impact factor: 3.791

3.  Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.

Authors:  N Ueda; K Kuno; S Ito
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

4.  Clinical use of immunosuppressive drugs: part II.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

5.  Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide.

Authors:  J S Cameron; C Chantler; C S Ogg; R H White
Journal:  Br Med J       Date:  1974-10-05

6.  Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome.

Authors:  Viktória Sümegi; Ibolya Haszon; Csaba Bereczki; Ferenc Papp; Sándor Túri
Journal:  Pediatr Nephrol       Date:  2008-03-07       Impact factor: 3.714

7.  Cyclophosphamide in treatment of minimal change nephrotic syndrome.

Authors:  I Shohet; J Meyerovitch; M Aladjem; H Boichis
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

8.  Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.

Authors:  Nicholas G Larkins; Isaac D Liu; Narelle S Willis; Jonathan C Craig; Elisabeth M Hodson
Journal:  Cochrane Database Syst Rev       Date:  2020-04-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.